je.st
news
Tag: bristolmyers
Bristol-Myers Squibb Appoints Giovanni Caforio, M.D., Chief Executive ...
2015-01-21 00:41:37| Biotech - Topix.net
Bristol-Myers Squibb Company today announced a number of leadership changes approved by its board of directors and effective at the close of the annual Shareholders' Meeting on May 5. "I want to thank Jim Cornelius for his many years at BMS," Andreotti said. "Through his leadership and strategic vision, Jim oversaw the successful transformation of our company.
Tags: executive
chief
giovanni
appoints
Analyst Update: Bristol-Myers Squibb Co, Achillion Pharmaceuticals, Inc., and Kimberly Clark Corp
2014-12-24 16:05:09| Paper - Topix.net
Bristol-Myers Squibb Co has been on a tear recently , outperforming the S&P 500 Index by more than 12 percentage points in the last 60 sessions. However, despite this morning's positive attention -- and the fact it touched a 13-year high of $61.77 out of the gate -- BMY has followed its pharmaceutical peers into the red , last seen at $58.74.
Tags: update
corp
clark
analyst
FDA approves new melanoma drug from Bristol-Myers
2014-12-22 23:54:34| Biotech - Topix.net
" The Food and Drug Administration granted accelerated approval Monday to a new drug from Bristol-Myers Squibb to treat the deadliest form of skin cancer. The agency approved Opdivo for patients with hard-to-treat melanoma that cannot be removed via surgery or has spread throughout the body.
Tags: drug
fda
approves
melanoma
Bristol-Myers: FDA blocks hepatitis C drug for...
2014-11-26 20:55:53| Biotech - Topix.net
U.S. regulators have declined to approve Bristol-Myers Squibb's daclatasvir as part of a combination hepatitis C treatment with another antiviral drug called asunaprevir. The company said Wednesday that data it submitted to the Food and Drug Administration to win approval of daclatasvir focused on that drug's use with asunaprevir.
Cancer therapy deal with Bristol-Myers Squibb boosts Five Prime drug
2014-11-25 08:34:39| Biotech - Topix.net
Five Prime Therapeutics Inc. snagged a deal with Bristol-Myers Squibb Co. around one of the leading drugs in the emerging class of cancer-fighting drugs known as immune checkpoint inhibitors.
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] next »